CliffBio
small molecule

THALLOUS CHLORIDE TL 201

THALLOUS CHLORIDE TL-201

Loss of exclusivity—loss of exclusivity
CompanyCurium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameTHALLOUS CHLORIDE TL 201
Active ingredientTHALLOUS CHLORIDE TL-201
Strength2mCi/ML
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalNovember 2006
Marketing statusDISCN

More from Curium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.